hims hers health - Search News

Hims & Hers shares tumble

Hims & Hers shares tumble after company misses on margin, says may stop selling some weight loss drugs

Hims & Hers Health reported fourth-quarter results on Monday that beat analysts' expectations, but the stock sank in extended trading.

Reuters · 6h

Hims & Hers warns its supply of compounded weight loss drugs could be 'constrained'

Hims & Hers said the U.S. FDA's decision that the shortage of Novo Nordisk's weight-loss and diabetes drugs had been resolved could constrain the telehealth firm's ability to continue providing access to compounded versions of the drugs on its platform once current inventory has been sold.

Investopedia on MSN · 4h

Hims & Hers Shares Plunge as Costs Tied to Weight-Loss Drugs Squeeze Margins

Hims & Hers Health shares plunged in extended trading Monday after the online healthcare provider reported falling margins as costs rose.

Fierce Healthcare6h

Hims & Hers projects weight loss business to hit $725M in 2025 despite GLP-1 market shift

Online health and wellness company Hims & Hers reported fourth-quarter earnings that beat Wall Street analysts' expectations ...

Hims & Hers Health, Inc. Reports Fourth Quarter and Full Year 2024 Financial Results

Hims & Hers Health, Inc. ("Hims & Hers" or the "Company", NYSE: HIMS), the leading health and wellness platform, today announced financial results for the fourth quarter and full year ended December ...

Hims & Hers Health Stock Drops After Q4 Report: EPS In-Line, Revenues Beat

Hims & Hers Health reports its fourth-quarter results after Monday's closing bell. Here's a look at the key figures from the ...

Hims & Hers Health 4Q Revenue Surges on Boost From Weight-Loss Treatments

Revenue excluding its GLP-1 offering increased 43% to $1.2 billion in 2024 from a year earlier, said Chief Financial Officer Yemi Okupe. Including sales of its weight-loss treatments, revenue surged ...

6don MSN

Hims & Hers Health Stock: A Millionaire-Maker in the Making?

Is Hims & Hers a millionaire-maker in the making? Yes! Or, at least, it can be. There is a possible future where Hims & Hers ...

Hims & Hers Health Q4 earnings fall short of estimates

Hims&Hers Health Inc (NYSE:HIMS) reported weaker-than-expected fourth-quarter earnings that overshadowed the telehealth company's revenue that topped Wall Street estimates.